CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Arch Biopartners plans US expansion of LSALT peptide trial

Phase 2LSALT peptidePositive
AI Analysis

Summary

Arch Biopartners announced plans to expand its Phase II clinical trial of LSALT peptide, a drug candidate for CS-AKI, to clinical sites in the United States.

Clinical Trial Data

Phase

Phase II

Importance:3/10
Sentiment:
0.30
Phase 2LSALT peptideCS-AKIUS expansionclinical trial
Related Companies

Read the original article

Published by Clinical Trials Arena on August 12, 2026 9:28 AM

Read Original